This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2016 Sep;21(3):154-6.

doi: 10.1111/jns.12173.

Severe, reversible nelarabine-induced neuropathy and myelopathy

Paola Alberti^{1

2

3

4}, Matteo Parma⁵, Pietro Pioltelli⁵, Enrico Maria Pogliani⁵, Elisabetta Terruzzi⁵, Alessandra Stasia⁵, Elisa Doni⁵, Caterina Cecchetti⁵, Guido Cavaletti^{1

2

3}

Affiliations

Affiliations

¹ Experimental Neurology Unit - School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
² Department of Neurology, S. Gerardo Hospital, Monza, Italy.
³ Milan Center for Neuroscience, Milan, Italy.
⁴ PhD Program in Neuroscience, University of Milano-Bicocca, Monza, Italy.
⁵ Department of Hematology, San Gerardo Hospital, Monza, Italy.

PMID: 27117493
DOI: 10.1111/jns.12173

Case Reports

Severe, reversible nelarabine-induced neuropathy and myelopathy

Paola Alberti et al. J Peripher Nerv Syst. 2016 Sep.

. 2016 Sep;21(3):154-6.

doi: 10.1111/jns.12173.

Authors

Paola Alberti^{1

2

3

4}, Matteo Parma⁵, Pietro Pioltelli⁵, Enrico Maria Pogliani⁵, Elisabetta Terruzzi⁵, Alessandra Stasia⁵, Elisa Doni⁵, Caterina Cecchetti⁵, Guido Cavaletti^{1

2

3}

Affiliations

¹ Experimental Neurology Unit - School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
² Department of Neurology, S. Gerardo Hospital, Monza, Italy.
³ Milan Center for Neuroscience, Milan, Italy.
⁴ PhD Program in Neuroscience, University of Milano-Bicocca, Monza, Italy.
⁵ Department of Hematology, San Gerardo Hospital, Monza, Italy.

PMID: 27117493
DOI: 10.1111/jns.12173

No abstract available

PubMed Disclaimer

Similar articles

Pediatric T-ALL complicated by irreversible nelarabine neurotoxicity.
Kanayama T, Imamura T, Nakagawa N, Osone S, Hosoi H. Kanayama T, et al. Pediatr Int. 2017 Jul;59(7):843-845. doi: 10.1111/ped.13303. Pediatr Int. 2017. PMID: 28745456 No abstract available.
MR imaging in nelarabine-induced myelopathy.
Dua SG, Jhaveri MD. Dua SG, et al. J Clin Neurosci. 2016 Jul;29:205-6. doi: 10.1016/j.jocn.2015.12.014. Epub 2016 Feb 16. J Clin Neurosci. 2016. PMID: 26899359 Review.
Irreversible myelopathy associated with nelaribine in T-cell acute lymphoblastic leukemia.
Gollard RP, Selco S. Gollard RP, et al. J Clin Oncol. 2013 Jul 1;31(19):e327-31. doi: 10.1200/JCO.2012.45.4728. Epub 2013 May 28. J Clin Oncol. 2013. PMID: 23715575 No abstract available.
Nelarabine-associated reversible Guillain-Barré-like syndrome or myelopathy in an adult patient with primary refractory T-lymphoblastic lymphoma.
Lalayanni C, Baldoumi E, Papayiannopoulos S, Tziola K, Saloum R, Anagnostopoulos A. Lalayanni C, et al. Curr Probl Cancer. 2017 Mar-Apr;41(2):138-143. doi: 10.1016/j.currproblcancer.2016.11.005. Epub 2016 Nov 17. Curr Probl Cancer. 2017. PMID: 28169005 Review.
Nelarabine-associated myelopathy in a patient with acute lymphoblastic leukaemia: Case report.
Amer-Salas N, González-Morcillo G, Rodríguez-Camacho JM, Cladera-Serra A. Amer-Salas N, et al. J Oncol Pharm Pract. 2021 Jan;27(1):244-249. doi: 10.1177/1078155220929747. Epub 2020 Jun 9. J Oncol Pharm Pract. 2021. PMID: 32517638

See all similar articles

Cited by

Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases.
Fukuta T, Tanaka T, Hashimoto T, Isahaya K, Kubo Y, Yamano Y, Satomi K, Hiraoka N, Shirakawa N, Arakawa A, Ogawa C, Nishimura N, Aoki J, Ito A, Inamoto Y, Kim SW, Fukuda T. Fukuta T, et al. Int J Hematol. 2023 Jun;117(6):933-940. doi: 10.1007/s12185-023-03539-5. Epub 2023 Jan 27. Int J Hematol. 2023. PMID: 36705847
Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia.
Bayón-Calderón F, Toribio ML, González-García S. Bayón-Calderón F, et al. Int J Mol Sci. 2020 Oct 16;21(20):7685. doi: 10.3390/ijms21207685. Int J Mol Sci. 2020. PMID: 33081391 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information